Business Context and Reporting Period
This Form 8-K Current Report from Lightwave Logic, Inc. covers events occurring on March 28, 2017, with the report filed on April 3, 2017. The filing primarily addresses corporate governance changes, specifically the departure of a director and the election of a new director to the Board.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed relates to compensation arrangements:
- Consulting Compensation: Approximately $212,693 paid to EOvation Advisors LLC (affiliated with the new director) over the past 12 months.
- Director Compensation: A monthly cash retainer of $9,000 for service on the Operations Committee.
- Equity Grant: An option to purchase 200,000 shares of common stock at an exercise price of $0.73 per share.
Material Changes
The material change reported is the composition of the Board of Directors:
- Resignation: Andrew Ashton resigned from the Board of Directors.
- Election: Dr. Frederick J. Leonberger was elected to fill the vacancy, with his term beginning April 1, 2017.
- Committee Assignment: Dr. Leonberger was named to the Operations Committee effective April 1, 2017.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of general business risks. It focuses on the background of the new director, Dr. Leonberger, noting his extensive experience in photonics and fiber optics, including prior leadership roles at JDS Uniphase Corporation and United Technologies Photonics. The filing notes that Dr. Leonberger has served as a senior advisor to the company since December 2011.
Investor Verification Checklist
- Verify the vesting schedule of the 200,000 stock options granted to Dr. Leonberger (50,000 immediate, remainder over three years).
- Review the potential financial impact of the 3% commission on non-security business investment transactions introduced by Dr. Leonberger.
- Confirm the total outstanding equity and potential dilution resulting from this new option grant.
- Examine the attached Exhibits 10.1 and 10.2 for full terms of the Director Agreement and Operations Committee Work.